Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: Analysis of the French Spontaneous Reporting Database for a controversial ADR

European Journal of Clinical Pharmacology

Volumn 68, Issue 11, 2012, Pages 1557-1560

  Maschino, Franck ^a   Hurault Delarue, Caroline ^a   Chebbane, Leila ^a   Fabry, Vincent ^a   Montastruc, Jean Louis ^a   Bagheri, Haleh ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Adverse drug reaction; Antiplatelet agents; Hemorrhage; Serotonin reuptake inhibitors

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EPISTAXIS; FEMALE; FRANCE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUSCLE BLEEDING; PHYSICIAN; PRIORITY JOURNAL; RESPIRATORY TRACT HEMORRHAGE; RISK ASSESSMENT; RISK FACTOR; SKIN BLEEDING; URINARY TRACT HEMORRHAGE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; DRUG INTERACTIONS; FEMALE; FRANCE; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 84867581942     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1268-8     Document Type: Article

References (26)

1. Turner MS, May DB, Arthur RR, Xiong GL (2007) Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks. J Intern Med 261:205-213
2. De Abajo FJ. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs Aging 28:345-67
3. Serebruany VL, Glassman AH, Malinin AI, Atar D, Sane DC, Oshrine BR, Ferguson JJ, O'Connor CM (2003) Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail 4:517-521 (Pubitemid 37021646)
4. Hougardy DM, Egberts TC, van der Graaf F, Brenninkmeijer VJ, Derijks LJ (2008) Serotonin transporter polymorphism and bleeding time during SSRI therapy. Br J Clin Pharmacol 5:761-766 (Pubitemid 351535089)
5. Maurer-Spurej E, Pittendreigh C, Solomons K (2004) The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 91:119-128 (Pubitemid 38120206)
6. Gasse C, Christensen S, Riis A, Mortensen PB, Adamsen S, Thomsen RW (2009) Preadmission use of SSRIs alone or in combination with NSAIDs and 30-day mortality after peptic ulcer bleeding. Scand J Gastroenterol 44:1288-1295
7. Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hansen JM, Hallas J (2009) An association between selective serotonin reuptake inhibitor use and serious uppergastrointestinal bleeding. Clin Gastroenterol Hepatol 12:1314-1321
8. Loke YK, Trivedi AN, Singh S (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31-40 (Pubitemid 350212624)
9. Vidal X, Ibáñez L, Vendrell L, Conforti A, Laporte JR, Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding (2008) Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study. Drug Saf 12:159-168 (Pubitemid 351158526)
10. Opatrny L, Delaney JA, Suissa S (2008) Gastrointestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 66:76-81 (Pubitemid 351822152)
11. Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, Kissela B, Broderick J, Woo D (2007) Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 11:3049-3051 (Pubitemid 350035702)
12. Kim DH, Daskalakis C, Whellan DJ, Whitman IR, Hohmann S, Medvedev S, Kraft WK (2009) Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol 10:1391-1395
13. De Abajo FJ, Jick H, Derby L, Jick S, Schmitz S (2000) Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 50:43-47 (Pubitemid 30416970)
14. Layton D, Clark DW, Pearce GL, Shakir SA (2001) Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 57:167-176 (Pubitemid 32449139)
15. Lugardon S, Lapeyre-Mestre M, Montastruc JL (2004) Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (rofexocib and celecoxib): a case/non-case study from the French Pharmacovigilance Database. Eur J Clin Pharmacol 9:673-677 (Pubitemid 40064601)
16. Do C, Huyghe E, Lapeyre-Mestre M, Montastruc JL, Bagheri H (2009) Statins and erectile dysfunction. Results of a case/non-case study using the French Pharmacovigilance Database. Drug Saf 7:591-597
17. Moore N, Noblet C, Kreft-Jais C, Lagier G, Ollagnier M, Imbs JL (1995) French Pharmacovigilance Database System: examples of utilisation. Thérapie 50:557-562 (Pubitemid 26020732)
18. Brown EG, Wood L, Wood S (1999) The medical dictionary for regulatory authorities. Drug Saf 2:109-117 (Pubitemid 29101275)
19. van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC (2002) A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11:3-10 (Pubitemid 34269590)
20. Wallerstedt SM, Gleerup H, Sundström A, Stigendal L, Ny L (2009) Risk of clinically relevant bleeding in warfarin-treated patientsinfluence of SSRI treatment. Pharmacoepidemiol Drug Saf 5:412-416
21. Abdel Salam OM (2004) Fluoxetine and sertraline stimulate gastric acid secretion via a vagal pathway in anaesthetized rats. Pharmacol Res 3:309-316 (Pubitemid 38844486)
22. Verdel BM, Souverein PC, Meenks SD, Heerdink ER, Leufkens HGM, Egberts TCG (2011) Use of serotoninergic drugs and the risk of bleeding. Clin Pharmacol Ther 1:89-96
23. Andrade C, Sandarsh S, Chethan KB, Nagesh KS (2010) Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 12:1565-1753
24. Boudal P, Sommet A, Bagheri H, Pathak A, Montastruc JL (2010) Bleedings induced by oral anticoagulants: a study of adverse drug reactions reported to Midi-Pyrénées PharmacoVigilance Centre between 2003 and 2006. Thérapie 65:567-569
25. Giezen TJ, Mantel-Teeuwisse AK, Meyboom RH, Straus SM, Leufkens HG, Egberts TC (2010) Mapping the safety profile of biologicals: a disproportionality analysis using the WHO Adverse Drug Reactions Database (VigiBase). Drug Saf 10:866-878
26. Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M (2011) Benefits and strengths of disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol 72:905-908